Zinase-D Tablet is a combination analgesic and anti-inflammatory medication containing Diclofenac 50 mg and Serratiopeptidase 10 mg. Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that effectively reduces pain, inflammation, and swelling by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby decreasing prostaglandin synthesis. Serratiopeptidase is a proteolytic enzyme that aids in reducing inflammation and edema by breaking down inflammatory mediators and promoting the drainage of fluids from inflamed tissues. This synergistic combination is indicated for the management of acute and chronic inflammatory conditions such as osteoarthritis, rheumatoid arthritis, musculoskeletal injuries, postoperative pain, and soft tissue inflammation. Zinase-D provides rapid relief from pain and inflammation while facilitating faster recovery by enhancing tissue healing. It is generally well-tolerated; however, caution is advised in patients with a history of gastrointestinal ulcers, bleeding disorders, renal or hepatic impairment, and hypersensitivity to NSAIDs or proteolytic enzymes. The medication should be taken as prescribed by a healthcare professional, typically after meals to minimize gastrointestinal discomfort. Regular monitoring may be necessary during prolonged therapy. Zinase-D Tablet offers an effective therapeutic option for patients requiring combined anti-inflammatory and analgesic treatment.